| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |